查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387364

CRP（C 反應蛋白）測試市場報告：2030 年趨勢、預測與競爭分析

C Reactive Protein Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

CRP（C 反應蛋白）檢測的趨勢與預測

預計到 2030 年，全球 CRP 檢測市場將達到約 47 億美元，2024 年至 2030 年年複合成長率為 3.1%。這個市場的主要促進因素是老年人口的增加、照護端設備的採用增加以及醫療服務需求的增加。全球CRP檢測市場前景廣闊，糖尿病、類風濕性關節炎、心血管疾病、發炎性腸道疾病市場蘊藏機會。

CRP 測試市場洞察

Lucintel 預測，免疫比濁法在預測期內將繼續成為最大的細分市場，因為它可以靈敏地測量各種 CRP 值。

在這個市場中，由於心血管疾病的快速增加以及對心血管疾病診斷和監測的需求不斷成長，心血管疾病仍將是最大的細分市場。

由於該地區發炎疾病的流行、不健康的生活方式的改變以及高昂的醫療保健支出，在預測期內，北美將繼續成為最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和業務風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球CRP測試市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球CRP測試市場趨勢（2018-2023）與預測（2024-2030）
  • 按分析類型分類的全球 CRP 測試市場
    • ELISA
    • 化學冷光免疫測量
    • 免疫比濁法
    • 其他
  • 按應用分類的全球 CRP 測試市場
    • 糖尿病
    • 類風濕性關節炎
    • 循環系統疾病
    • 發炎性腸道疾病
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 按地區分類的全球 CRP 測試市場
  • 北美CRP檢測市場
  • 歐洲CRP測試市場
  • 亞太CRP測試市場
  • 其他地區CRP檢測市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按分析類型分類的全球 CRP 測試市場成長機會
    • 全球 CRP 測試市場成長機會（按應用）
    • 按地區分類的全球 CRP 測試市場成長機會
  • 全球CRP檢測市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球 CRP 檢測市場的產能
    • 全球CRP檢測市場的合併、收購與合資
    • 認證和許可

第7章 主要企業概況

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech
簡介目錄

C Reactive Protein Testing Trends and Forecast

The future of the global C reactive protein testing market looks promising with opportunities in the diabetes, rheumatoid arthritis, cardiovascular disease, and inflammatory bowel disease markets. The global C reactive protein testing market is expected to reach an estimated $4.7 billion by 2030 with a CAGR of 3.1% from 2024 to 2030. The major drivers for this market are increasing geriatric population, growing adoption of point-of-care devices, and rising demand for healthcare services.

A more than 150-page report is developed to help in your business decisions.

C Reactive Protein Testing by Segment

The study includes a forecast for the global C reactive protein testing by assay type, application, and region.

C Reactive Protein Testing Market by Assay Type [Shipment Analysis by Value from 2018 to 2030]:

  • Enzyme-Linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Immunoturbidimetric Assay
  • Others

C Reactive Protein Testing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Diabetes
  • Rheumatoid Arthritis
  • Cardiovascular Disease
  • Inflammatory Bowel Disease
  • Others

C Reactive Protein Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of C Reactive Protein Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies C reactive protein testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the C reactive protein testing companies profiled in this report include-

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

C Reactive Protein Testing Market Insights

Lucintel forecasts that immunoturbidimetric assay will remain the largest segment over the forecast period as it provides high sensitivity for measuring a wide range of CRP levels.

Within this market, cardiovascular disease will remain the largest segment due to surge in cardiovascular diseases and growing need to diagnose and monitor cardiovascular diseases.

North America will remain the largest region over the forecast period due to growing prevalence of inflammatory diseases, change in unhealthy lifestyle, and high healthcare expenditure in the region.

Features of the Global C Reactive Protein Testing Market

Market Size Estimates: C reactive protein testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: C reactive protein testing market size by assay type, application, and region in terms of value ($B).

Regional Analysis: C reactive protein testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different assay types, applications, and regions for the C reactive protein testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the C reactive protein testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the C reactive protein testing market size?

Answer: The global C reactive protein testing market is expected to reach an estimated $4.7 billion by 2030.

Q2. What is the growth forecast for C reactive protein testing market?

Answer: The global C reactive protein testing market is expected to grow with a CAGR of 3.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the C reactive protein testing market?

Answer: The major drivers for this market are increasing geriatric population, growing adoption of point-of-care devices, and rising demand for healthcare services.

Q4. What are the major segments for C reactive protein testing market?

Answer: The future of the C reactive protein testing market looks promising with opportunities in the diabetes, rheumatoid arthritis, cardiovascular disease, and inflammatory bowel disease markets.

Q5. Who are the key C reactive protein testing market companies?

Answer: Some of the key C reactive protein testing companies are as follows:

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

Q6. Which C reactive protein testing market segment will be the largest in future?

Answer: Lucintel forecasts that immunoturbidimetric assay will remain the largest segment over the forecast period as it provides high sensitivity for measuring a wide range of CRP levels.

Q7. In C reactive protein testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing prevalence of inflammatory diseases, change in unhealthy lifestyle, and high healthcare expenditure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the C reactive protein testing market by assay type (enzyme-linked immunosorbent assay, chemiluminescence immunoassay, immunoturbidimetric assay, and others), application (diabetes, rheumatoid arthritis, cardiovascular disease, inflammatory bowel disease, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global C Reactive Protein Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global C Reactive Protein Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global C Reactive Protein Testing Market by Assay Type
    • 3.3.1: Enzyme-Linked Immunosorbent Assay
    • 3.3.2: Chemiluminescence Immunoassay
    • 3.3.3: Immunoturbidimetric Assay
    • 3.3.4: Others
  • 3.4: Global C Reactive Protein Testing Market by Application
    • 3.4.1: Diabetes
    • 3.4.2: Rheumatoid Arthritis
    • 3.4.3: Cardiovascular Disease
    • 3.4.4: Inflammatory Bowel Disease
    • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global C Reactive Protein Testing Market by Region
  • 4.2: North American C Reactive Protein Testing Market
    • 4.2.2: North American C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others
  • 4.3: European C Reactive Protein Testing Market
    • 4.3.1: European C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.3.2: European C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others
  • 4.4: APAC C Reactive Protein Testing Market
    • 4.4.1: APAC C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.4.2: APAC C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others
  • 4.5: ROW C Reactive Protein Testing Market
    • 4.5.1: ROW C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.5.2: ROW C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global C Reactive Protein Testing Market by Assay Type
    • 6.1.2: Growth Opportunities for the Global C Reactive Protein Testing Market by Application
    • 6.1.3: Growth Opportunities for the Global C Reactive Protein Testing Market by Region
  • 6.2: Emerging Trends in the Global C Reactive Protein Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global C Reactive Protein Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global C Reactive Protein Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Danaher
  • 7.4: Quest Diagnostics
  • 7.5: Siemens Healthineers
  • 7.6: Abbott
  • 7.7: Merck KGaAA
  • 7.8: Zoetis
  • 7.9: Ortho Clinical Diagnostics
  • 7.10: Getein Biotech